BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

The market for multiplex biomarker imaging is anticipated to reach a valuation of USD 1,631.4 million by 2034, up from USD ...

Throughout his career, he has held key positions in private and public ... In 2024, we established a license and research collaboration with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) to ...

Joe Biden and Donald Trump pledged to deliver a “smooth” transfer of power in the US as they met in the Oval Office for the first time since last week’s presidential election. “Congratulations,” Biden ...

Throughout his career, he has held key positions in private and public ... In 2024, we established a license and research collaboration with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) to ...

Prior to joining Alexion in 2015, George was employed by Merck & Co., Inc. for 25 years in IT positions of increasing responsibility. He served as Vice President, Manufacturing and Supply Chain ...

Most recently, he served as Chief Operating Officer of Prometheus Biosciences, a biotechnology company focused on gastrointestinal diseases that was acquired by Merck for $10.8 billion in 2023. Prior ...

Donald Trump has chosen Tulsi Gabbard, a former Democratic congresswoman from Hawaii, to be the director of national ...

So, we've made a lot of progress. Miller: I think the public perception doesn't match the actual scientific progress because that is a huge change even during our careers. But radiation sounds scary.

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

An analyst note raising questions about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis ...

TileDB, the database designed for scientific discovery, announced today it is now utilized by 50% of the top 20 global pharmaceutical companies, including industry giant Boehringer Ingelheim. This ...